Literature DB >> 15054509

Prospective validity of measuring angina severity with Canadian Cardiovascular Society class: The ACRE study.

Harry Hemingway1, Natalie K Fitzpatrick, Shamini Gnani, Gene Feder, Neil Walker, Angela M Crook, Patrick Magee, Adam Timmis.   

Abstract

BACKGROUND: Although the prevalence of angina remains high, the importance of grading angina severity is unclear.
OBJECTIVES: To determine the extent to which angina severity is associated with angiographic findings, and the rate of revascularization, mortality and nonfatal myocardial infarction.
METHODS: Prospective, population-based study with a 2.5-year follow-up of 2849 consecutive patients with angina undergoing coronary angiography at Barts and the London NHS Trust, London, United Kingdom, in the Appropriateness of Coronary Revascularisation (ACRE) study. Angina severity was assessed with the Canadian Cardiovascular Society (CCS) classification, ranging from class I (mild) to IV (severe). Outcome measures were revascularization rates, and all-cause mortality and nonfatal myocardial infarction.
RESULTS: In age-adjusted analyses, a higher CCS class was linearly associated (P<0.001) with a higher number of diseased vessels and impaired left ventricular function. When adjusting for age, sex, smoking, history of hypertension, diabetes, number of diseased vessels, left ventricular function, use of acetylsalicylic acid, beta-blockers or statins, and revascularization status (for death and nonfatal myocardial infarction), a higher CCS class was linearly associated with higher coronary angioplasty (P<0.001) and bypass graft (P=0.03) rates, and lower all-cause mortality and nonfatal myocardial infarction (P<0.001; CCS IV versus I: hazard ratio 2.44, 95% CI 1.46 to 4.09).
CONCLUSION: CCS class was linearly associated with angiographic findings, revascularization rates, mortality and nonfatal myocardial infarction. These findings support the importance of a four-level grading of symptom severity among angina patients.

Entities:  

Mesh:

Year:  2004        PMID: 15054509

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  13 in total

1.  Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification.

Authors:  Padma Kaul; C David Naylor; Paul W Armstrong; Daniel B Mark; Pierre Theroux; Gilles R Dagenais
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

2.  Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation.

Authors:  William E Lawson; John C K Hui; Elizabeth D Kennard; Sheryl F Kelsey; Andrew D Michaels; Ozlem Soran
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

3.  Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.

Authors:  Gilles R Dagenais; Jiang Lu; David P Faxon; Peter Bogaty; Dale Adler; Francisco Fuentes; Jorge Escobedo; Ashok Krishnaswami; James Slater; Robert L Frye
Journal:  J Am Coll Cardiol       Date:  2013-02-19       Impact factor: 24.094

4.  High probability of disease in angina pectoris patients: is clinical estimation reliable?

Authors:  Poul F Høilund-Carlsen; Allan Johansen; Werner Vach; Henrik Wulff Christensen; Mette Møldrup; Torben Haghfelt
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

5.  A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery.

Authors:  Neesh Pannu; Michelle Graham; Scott Klarenbach; Steven Meyer; Teresa Kieser; Brenda Hemmelgarn; Feng Ye; Matthew James
Journal:  CMAJ       Date:  2016-06-13       Impact factor: 8.262

Review 6.  The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.

Authors:  Andrew E Moran; Mohammad H Forouzanfar; Gregory A Roth; George A Mensah; Majid Ezzati; Abraham Flaxman; Christopher J L Murray; Mohsen Naghavi
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

7.  Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study.

Authors:  Andrew E Moran; Keane Y Tzong; Mohammad H Forouzanfar; Gregory A Rothy; George A Mensah; Majid Ezzati; Christopher J L Murray; Mohsen Naghavi
Journal:  Glob Heart       Date:  2014-03

8.  Base Rates of Depressive Symptoms in Patients with Coronary Heart Disease: An Individual Symptom Analysis.

Authors:  Sebastian Kohlmann; Benjamin Gierk; Alexandra M Murray; Arne Scholl; Marco Lehmann; Bernd Löwe
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.

Authors:  Adrianna Murphy; Catherine O Johnson; Gregory A Roth; Mohammad H Forouzanfar; Mohsen Naghavi; Marie Ng; Nana Pogosova; Theo Vos; Christopher J L Murray; Andrew E Moran
Journal:  Heart       Date:  2017-09-07       Impact factor: 5.994

10.  Echocardiographic measurements of epicardial adipose tissue and comparative ability to predict adverse cardiovascular outcomes in patients with coronary artery disease.

Authors:  Julieta D Morales-Portano; Juan Ángel Peraza-Zaldivar; Juan A Suárez-Cuenca; Rocío Aceves-Millán; Lilia Amezcua-Gómez; Carlos H Ixcamparij-Rosales; Rafael Trujillo-Cortés; Rogelio Robledo-Nolasco; Paul Mondragón-Terán; Rebeca Pérez-Cabeza de Vaca; Rolando Hernández-Muñoz; Alberto Melchor-López; Mani A Vannan; Alberto Francisco Rubio-Guerra
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.